WELLINGTON MANAGEMENT GROUP LLP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 192 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$17,461,000
+2.1%
167,428
-2.6%
0.00%0.0%
Q3 2019$17,104,000
-16.0%
171,822
-3.6%
0.00%
-20.0%
Q2 2019$20,355,000
-5.7%
178,319
+3.8%
0.01%0.0%
Q1 2019$21,596,000
+2356.9%
171,792
+3947.9%
0.01%
Q2 2018$879,000
+7.3%
4,244
-14.4%
0.00%
Q1 2018$819,000
+21.5%
4,960
+0.8%
0.00%
Q4 2017$674,000
+0.6%
4,9190.0%0.00%
Q3 2017$670,000
+12.2%
4,9190.0%0.00%
Q2 2017$597,000
-71.8%
4,919
-74.8%
0.00%
-100.0%
Q4 2015$2,119,000
-1.1%
19,546
-21.9%
0.00%0.0%
Q3 2015$2,143,000
+66.5%
25,019
+96.2%
0.00%
Q2 2015$1,287,000
-45.3%
12,751
-58.2%
0.00%
-100.0%
Q1 2015$2,353,000
+20.7%
30,520
-16.7%
0.00%0.0%
Q4 2014$1,949,000
+5.5%
36,620
-6.9%
0.00%0.0%
Q3 2014$1,848,000
+15.4%
39,320
+52.9%
0.00%
Q2 2014$1,602,000
-5.2%
25,714
+2.4%
0.00%
Q1 2014$1,690,000
-85.3%
25,120
-88.5%
0.00%
-100.0%
Q4 2013$11,479,000
-48.5%
218,235
-57.6%
0.00%
-57.1%
Q3 2013$22,299,000
-1.1%
515,235
-14.5%
0.01%0.0%
Q2 2013$22,551,000602,6350.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders